JPWO2020203812A1 - - Google Patents

Info

Publication number
JPWO2020203812A1
JPWO2020203812A1 JP2021512025A JP2021512025A JPWO2020203812A1 JP WO2020203812 A1 JPWO2020203812 A1 JP WO2020203812A1 JP 2021512025 A JP2021512025 A JP 2021512025A JP 2021512025 A JP2021512025 A JP 2021512025A JP WO2020203812 A1 JPWO2020203812 A1 JP WO2020203812A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021512025A
Other languages
Japanese (ja)
Other versions
JP7366377B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2020203812A1 publication Critical patent/JPWO2020203812A1/ja
Application granted granted Critical
Publication of JP7366377B2 publication Critical patent/JP7366377B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/612—Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/616—Echinodermata, e.g. starfish, sea cucumbers or sea urchins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Insects & Arthropods (AREA)
  • Zoology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Transplantation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2021512025A 2019-03-29 2020-03-27 魚介類由来成分による低酸素応答制御 Active JP7366377B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2019068141 2019-03-29
JP2019068141 2019-03-29
JP2019145435 2019-08-07
JP2019145435 2019-08-07
PCT/JP2020/014124 WO2020203812A1 (ja) 2019-03-29 2020-03-27 魚介類由来成分による低酸素応答制御

Publications (2)

Publication Number Publication Date
JPWO2020203812A1 true JPWO2020203812A1 (fi) 2020-10-08
JP7366377B2 JP7366377B2 (ja) 2023-10-23

Family

ID=72668466

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021512025A Active JP7366377B2 (ja) 2019-03-29 2020-03-27 魚介類由来成分による低酸素応答制御

Country Status (2)

Country Link
JP (1) JP7366377B2 (fi)
WO (1) WO2020203812A1 (fi)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09512563A (ja) * 1994-04-28 1997-12-16 レ ラボラトワール エテルナ インコーポレイティド 抗脈管形成活性及び腫瘍退行に対する作用を有するサメ軟骨の抽出物並びにその製法
JP2000256398A (ja) * 1999-03-09 2000-09-19 Katakura Chikkarin Co Ltd 魚皮由来コラーゲン及びそれを含む化粧料
JP2001197868A (ja) * 2000-01-17 2001-07-24 Takara Shuzo Co Ltd 調味料の製造方法
WO2018088566A1 (ja) * 2016-11-14 2018-05-17 学校法人慶應義塾 虚血性疾患、緑内障、視神経疾患、網膜変性疾患、血管新生性網膜疾患、がん、神経変性、もしくは自己免疫疾患の治療又は予防剤、及び低酸素誘導因子阻害剤

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09512563A (ja) * 1994-04-28 1997-12-16 レ ラボラトワール エテルナ インコーポレイティド 抗脈管形成活性及び腫瘍退行に対する作用を有するサメ軟骨の抽出物並びにその製法
JP2000256398A (ja) * 1999-03-09 2000-09-19 Katakura Chikkarin Co Ltd 魚皮由来コラーゲン及びそれを含む化粧料
JP2001197868A (ja) * 2000-01-17 2001-07-24 Takara Shuzo Co Ltd 調味料の製造方法
WO2018088566A1 (ja) * 2016-11-14 2018-05-17 学校法人慶應義塾 虚血性疾患、緑内障、視神経疾患、網膜変性疾患、血管新生性網膜疾患、がん、神経変性、もしくは自己免疫疾患の治療又は予防剤、及び低酸素誘導因子阻害剤

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BAHARARA, J., ET AL.: "Apoptosis inducing capacity of Holothuria arenicola in CT26 colon carcinoma cells in vitro and in vi", IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2016, VOL.19, NO.4, PP.358-365, JPN6020018907, ISSN: 0005024074 *
日本食品工業学会誌, vol. 13, no. 1, JPN6023012143, 1966, pages 37 - 43, ISSN: 0005024075 *

Also Published As

Publication number Publication date
WO2020203812A1 (ja) 2020-10-08
JP7366377B2 (ja) 2023-10-23

Similar Documents

Publication Publication Date Title
BR112019017762A2 (fi)
BR112021017339A2 (fi)
BR112021013854A2 (fi)
BR112021017939A2 (fi)
BR112021017892A2 (fi)
BR112019016141A2 (fi)
AU2020104490A4 (fi)
BR112021017738A2 (fi)
BR112021017782A2 (fi)
BR112019016138A2 (fi)
BR112021018168A2 (fi)
BR112021017728A2 (fi)
BR112021008711A2 (fi)
BR112021017234A2 (fi)
BR112021017355A2 (fi)
BR112021017703A2 (fi)
BR112021018102A2 (fi)
BR112021017173A2 (fi)
BR112021017083A2 (fi)
BR112021017637A2 (fi)
BR112021012348A2 (fi)
BR112021018084A2 (fi)
BR112021018093A2 (fi)
BR112021013944A2 (fi)
BR112021013128A2 (fi)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20211109

AA64 Notification of invalidation of claim of internal priority (with term)

Free format text: JAPANESE INTERMEDIATE CODE: A241764

Effective date: 20220106

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20220118

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221031

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221227

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230329

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230508

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230629

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20230731

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20230731

TRDD Decision of grant or rejection written
RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20230828

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230905

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20231002

R150 Certificate of patent or registration of utility model

Ref document number: 7366377

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150